ArticleInternational cancer conference journal2026
Emphysematous osteomyelitis in hematological malignancies: tales of two cases.
Article in International cancer conference journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Emphysematous osteomyelitis (EOM) is defined as the presence of gas forming bacteria within bones. It is seen in patients with morbid conditions like immunosuppression, diabetes, patients on chemotherapy, in cancer patients and in intravenous drug abusers. We present two cases of emphysematous osteomyelitis in patients with hematological malignancies; lymphoma and leukemia. Both the patients had similar clinical presentations with fever, localized swelling, and pain. Both patients underwent sonography (USG) and contrast-enhanced computed tomography (CECT) and imaging diagnosis of EOM was made. Microbiological confirmation of the causative organism was done and patients were started on appropriate antibiotics. Both patients responded very well to the treatment. Imaging findings and treatment outcomes are discussed, highlighting the challenges in managing this rare complication.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.